Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Zuclopenthixol decanoate poisoning |
Causative agent (attribute) |
True |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
Accidental zuclopenthixol decanoate poisoning |
Causative agent (attribute) |
False |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
|
Intentional zuclopenthixol decanoate poisoning |
Causative agent (attribute) |
False |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
|
intoxication par le décanoate de zuclopenthixol d'intention indéterminée |
Causative agent (attribute) |
False |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
Zuclopenthixol decanoate adverse reaction |
Causative agent (attribute) |
True |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
allergie au décanoate de zuclopenthixol |
Causative agent (attribute) |
False |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
|
Accidental zuclopenthixol decanoate overdose |
Causative agent (attribute) |
True |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
Intentional zuclopenthixol decanoate overdose |
Causative agent (attribute) |
True |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
surdose de décanoate de zuclopenthixol d'intention indéterminée |
Causative agent (attribute) |
False |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
Product containing zuclopenthixol decanoate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
|
décanoate de zuclopenthixol 200 mg/mL, ampoule de 1 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
|
décanoate de zuclopenthixol 500 mg/mL, ampoule de 1 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
|
Accidental zuclopenthixol decanoate poisoning |
Causative agent (attribute) |
True |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
Intentional zuclopenthixol decanoate poisoning |
Causative agent (attribute) |
True |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
Zuclopenthixol decanoate overdose |
Causative agent (attribute) |
True |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
allergie au décanoate de zuclopenthixol |
Causative agent (attribute) |
False |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
Product containing zuclopenthixol decanoate in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
|
Product containing precisely zuclopenthixol decanoate 200 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely zuclopenthixol decanoate 200 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely zuclopenthixol decanoate 500 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely zuclopenthixol decanoate 500 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
Zuclopenthixol decanoate 200 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
Zuclopenthixol decanoate 200 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
Zuclopenthixol decanoate 500 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |
Zuclopenthixol decanoate 500 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Zuclopenthixol decanoate (substance) |
Inferred relationship |
Some |
1 |